Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/54541
Title: PDGFRα/β and VEGFR2 polymorphisms in colorectal cancer: incidence and implications in clinical outcome
Authors: 
Filiation: Servicio de Anatomía Patológica. Hospital Universitario de Fuenlabrada
Mesh: 
Decs: 
Issue Date: 12-Nov-2012
Publisher: Springer Science and Business Media LLC
Citation: Estévez García P, Castaño Pascual A, Martín AC, López Ríos F, Iglesias J, Muñoz Galván S, et al. PDGFRalpha/beta and VEGFR2 polymorphisms in colorectal cancer: incidence and implications in clinical outcome. BMC Cancer. 2012;12:514.
Abstract: Angiogenesis plays an essential role in tumor growth and metastasis, and is a major target in cancer therapy. VEGFR and PDGFR are key players involved in this process. The purpose of this study was to assess the incidence of genetic variants in these receptors and its potential clinical implications in colorectal cancer (CRC).
PMID: 23146028
URI: https://hdl.handle.net/20.500.12530/54541
Rights: info:eu-repo/semantics/openAccess
Appears in Collections:Hospitales > H. U. de Fuenlabrada > Artículos

Files in This Item:
File Description SizeFormat 
BMC Cancer.pdf515.05 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons